Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction

LAN Youling; LI Tianfa; ZHAN Yatong; CHEN Yan'e; GUAN Fuqing; YANG Yang

doi:10.7619/jcmp.20240909

Journal of Clinical Medicine in Practice > 2024 > 28(15): 3-8, 13. > DOI: 10.7619/jcmp.20240909

LAN Youling, LI Tianfa, ZHAN Yatong, CHEN Yan'e, GUAN Fuqing, YANG Yang. Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 3-8, 13. DOI: 10.7619/jcmp.20240909

Citation:

PDF (2400 KB)

Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction

1.
the First Department of Cardiology, the First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570102
2.
Department of Respiratory Medicine, the First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570102

More Information

Received Date: March 04, 2024
Revised Date: May 19, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3 (NLRP3)/cysteine-aspartic acid-specific protease 1 (Caspase-1) mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction (AMI).
Methods
A total of 40 rats were randomly divided into sham operation group, model group, betaloc group (0.9 mg/kg), and combination group (0.9 mg/kg betaloc combined with 6 mL/kg Shenfu Injection), with 10 rats in each group. The rats were treated by gavage continuously for 3 weeks. The levels of serum troponin I (cTnI), creatine kinase-MB (CK-MB), interleukin (IL)-6, IL-1β, and tumor necrosis factor-α (TNF-α) in rats were detected before modeling, after modeling, and at 3 weeks of treatment. Echocardiographic parameters such as left ventricular ejection fraction (LVEF), left ventricular end-systolic diameter(LVESD), left ventricular end-diastolic diameter (LVEDD), and myocardial infarction area were compared among groups after modeling and at 3 weeks of treatment. Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) and Western blot were used to detect the mRNA and protein expression levels of NLRP3 and Caspase-1 in the myocardium.
Results
Compared with the sham operation group, the levels of cTnI, CK-MB, IL-6, IL-1β, TNF-α, myocardial infarction area, and the expressions of NLRP3 mRNA and Caspase-1 mRNA in the model group were significantly increased after modeling and at 3 weeks of treatment (P < 0.05); compared with the model group, the levels of cTnI, CK-MB, IL-6, IL-1β, TNF-α, myocardial infarction area, and the expressions of NLRP3 mRNA and Caspase-1 mRNA in the betaloc group and the combination group were significantly decreased at 3 weeks of treatment, and the above indicators in the combination group were significantly lower than those in the betaloc group (P < 0.05).
Conclusion
Adjuvant therapy of Shenfu Injection for AMI can further alleviate myocardial cell injury, shorten infarction size, and inhibit inflammatory response and pyroptosis activity.

FullText(HTML)

References (27)

References

[1]	邓志杰, 董子洵, 刘家伟, 等. 参附注射液综合评价研究[J]. 中国临床药理学杂志, 2023, 39(24): 3682-3692. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202324030.htm
[2]	宋玉莹, 崔琳, 何玉凤, 等. 参附益心颗粒对心肌梗死后心力衰竭大鼠线粒体动力学的影响[J]. 中国实验方剂学杂志, 2024, 30(11): 87-94. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202411011.htm
[3]	徐坡, 谢靖, 邵妤, 等. 参附注射液治疗脓毒症相关心肌功能障碍临床观察[J]. 山西中医, 2023, 39(12): 11-14. https://www.cnki.com.cn/Article/CJFDTOTAL-SHIX202312005.htm
[4]	CHEN R J, RUI Q L, WANG Q, et al. Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats[J]. Chin J Nat Med, 2020, 18(3): 226-233.
[5]	ZHANG J, HUANG L L, SHI X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway[J]. Aging, 2020, 12(23): 24270-24287. doi: 10.18632/aging.202143
[6]	ZHANG B F, LIU G, HUANG B, et al. KDM3A attenuates myocardial ischemic and reperfusion injury by ameliorating cardiac microvascular endothelial cell pyroptosis[J]. Oxid Med Cell Longev, 2022, 2022: 4622520.
[7]	王贝贝, 郭丽叶, 刘姜倩, 等. 针刺联合参附注射液对心脏骤停患者心肺复苏后脑损伤及血流动力学的影响[J]. 中国现代医生, 2023, 61(34): 76-80. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202334020.htm
[8]	刘豫, 高春雁, 武伟, 等. 参附注射液对广西巴马小型猪离体空跳心脏心肌保护的研究[J]. 河北医药, 2023, 45(23): 3554-3558. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ202323007.htm
[9]	叶润杰, 黄培红. 基于网络药理学探讨加味参附颗粒治疗慢性心力衰竭的潜在靶点及作用机制[J]. 广州中医药大学学报, 2023, 40(11): 2867-2876. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202311025.htm
[10]	刘海燕, 于晶晶, 师志云, 等. 基于PI3K-AKT-mTOR信号通路探讨参附注射液对心力衰竭大鼠的作用及其机制[J]. 现代生物医学进展, 2023, 23(22): 4218-4222. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202322004.htm
[11]	WANG X, GUO R F, GUO Y Y, et al. Rationale and design of the RESTORE trial: a multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI[J]. Am Heart J, 2023, 260: 9-17. doi: 10.1016/j.ahj.2023.02.005
[12]	CHEN X, LI Y Q, LI J J, et al. Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats[J]. J Ethnopharmacol, 2022, 285: 114841. doi: 10.1016/j.jep.2021.114841
[13]	WANG X, HU Y, WANG Y G, et al. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis[J]. Biochim Biol Cell, 2021, 99(5): 655-665. doi: 10.1139/bcb-2020-0672
[14]	LI Y X, WANG Y, GUO H, et al. IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis[J]. Mol Med Rep, 2021, 25(2): 40. doi: 10.3892/mmr.2021.12556
[15]	MAO Q, LIANG X L, ZHANG C L, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis[J]. Stem Cell Res Ther, 2019, 10(1): 393. doi: 10.1186/s13287-019-1522-4
[16]	范星宇, 廖晓倩, 王梓仪, 等. NLRP3炎症小体介导的细胞焦亡在慢性心力衰竭中的机制及中医药研究进展[J]. 中国中药杂志, 2024, 49(8): 2106-2116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202408012.htm
[17]	原平利, 刘刚, 马兰香, 等. 毛兰素通过抑制NLRP3炎症体介导的细胞焦亡减轻心肌缺血再灌注损伤[J]. 山西医科大学学报, 2023, 54(9): 1200-1207. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYX202309005.htm
[18]	SUN W J, LU H Q, LYU L C, et al. Gastrodin ameliorates microvascular reperfusion injury-induced pyroptosis by regulating the NLRP3/caspase-1 pathway[J]. J Physiol Biochem, 2019, 75(4): 531-547. doi: 10.1007/s13105-019-00702-7
[19]	YAO F, JIN Z, ZHENG Z H, et al. HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells[J]. Cell Death Discov, 2022, 8: 112.
[20]	JIANG X J, MA C Y, GAO Y B, et al. Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis[J]. J Ethnopharmacol, 2023, 304: 116011. doi: 10.1016/j.jep.2022.116011
[21]	TANG Y S, ZHAO Y H, ZHONG Y, et al. Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway[J]. Inflamm Res, 2019, 68(9): 727-738. doi: 10.1007/s00011-019-01256-6
[22]	赵雯, 张勇, 张波, 等. 红花黄色素调节NF-κB/NLRP3信号通路对心肌梗死大鼠心肌细胞焦亡和炎性损伤的影响[J]. 河北医学, 2023, 29(1): 25-31. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX202301005.htm
[23]	马迪, 张秀静, 王威, 等. 柴胡加龙骨牡蛎汤含药血清调控NLRP3/Caspase-1通路介导心肌细胞焦亡的研究[J]. 现代中西医结合杂志, 2023, 9(2): 183-187, 204. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH202302007.htm
[24]	张杼惠, 曹蛟, 刘蓉芳, 等. 基于ROS/TXNIP/NLRP3通路的柴胡三参胶囊对心肌缺血再灌注损伤大鼠心肌细胞焦亡的影响[J]. 中国中医药信息杂志, 2023, 30(5): 114-120. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY202305019.htm
[25]	JIA Y F, CUI R X, WANG C, et al. Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway[J]. Redox Biol, 2020, 32: 101534.
[26]	YAN H L, LUO B, WU X Y, et al. Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer[J]. Int J Biol Sci, 2021, 17(10): 2606-2621.
[27]	JIANG S Q, ZHANG H, LI X, et al. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/Caspase-1/GSDMD pyroptosis pathway[J]. J Steroid Biochem Mol Biol, 2021, 206: 105789.

[1]	CHENG Hongjuan, ZHOU Wei, ZHA Bai, WANG Jianping, CHEN Qiming, WU Xiaorong. Effects of individualized nutrition intervention on sarcopenia and quality of life in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 62-67. DOI: 10.7619/jcmp.20231695
[2]	MENG Junping, LI Zhanting, ZHANG Han, ZHAO Jie. Effects of different dialysis methods for patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 38-41. DOI: 10.7619/jcmp.202015011
[3]	ZHANG Yan, YU Shan, WANG Xiaomin. Effect of intensive nutrition nursing on nutritional status and calcium and phosphorus metabolism in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2018, (20): 35-38. DOI: 10.7619/jcmp.201820011
[4]	WEI Leilei, XUE Pengshi. Targeted nutritional nursing for patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2018, (4): 34-37. DOI: 10.7619/jcmp.201804010
[5]	WANG Donghui, LIU Zhihong, REN Ke, ZHANG Wei. Effect of humanized nursing intervention in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2017, (20): 28-31. DOI: 10.7619/jcmp.201720009
[6]	GAO Yun, MA Yuhua, XIA zhiyin, CAO Hongmei. Effects of different auricular acupoints stimulating on sleep quality of maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2017, (14): 58-60. DOI: 10.7619/jcmp.201714017
[7]	FENG Xiaodong, ZHOU Lijuan, SHANG Hong, LI Jiaying, TONG Yang, WANG Xiaomin. Perioperative nursing of maintenance hemodialysis patients with secondary hyperparathyroidism[J]. Journal of Clinical Medicine in Practice, 2017, (2): 57-59. DOI: 10.7619/jcmp.201702018
[8]	ZHU Yalin. Effect of nursing intervention on treatment of maintenance hemodialysis patients with sleep disorders[J]. Journal of Clinical Medicine in Practice, 2016, (10): 32-34,38. DOI: 10.7619/jcmp.201610011
[9]	FU Qigang, LIU Congfeng, LI Liekuan, SONG Yuchun, LIU Yong. Effect of three-section health education for patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2016, (6): 47-49. DOI: 10.7619/jcmp.201606015
[10]	LYU Aie, LI Xiaoyun. The effect of nutrition support nursing intervention on quality of life in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2015, (6): 23-26. DOI: 10.7619/jcmp.201506008

Cited By

Cited by

Periodical cited type(2)

1.	郭红歌. 人工上油应用于轴节类手术器械的效果分析. 辽宁医学杂志. 2019(02): 101-103 .
2.	李秀英, 路珊珊. 一起灭菌后手术器械表面液体珠现象的调查. 中国感染控制杂志. 2019(07): 684-686 .

Other cited types(0)

Get Citation

PDF

XML

Article views (160) PDF downloads (21) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction